ATRC Stock Cash Flow Statements

AtriCure Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

AtriCure Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30

cash flows from operating activities:
net income	-6,190,000	-6,747,000	-15,568,000	-7,853,000	-8,008,000	-13,269,000	-9,789,000	-9,055,000	-5,118,000	-6,476,000	-4,170,000	-12,272,000	-14,841,000	-15,183,000	-13,741,000	97,108,000	-16,251,000	-16,917,000	-18,562,000	-4,949,000	-8,236,000	-16,408,000	-16,096,000	-9,362,000	-4,101,000	-5,635,000	-3,430,000	-7,235,000	-338,000	-10,134,000	-2,580,000	-7,246,000	-6,883,000	-10,183,000	-8,625,000	-6,783,000	-8,206,000	-9,724,000	-10,914,000	-6,141,000	-4,891,000	-5,266,000	-5,344,000	-466,000	-2,692,000	-7,709,000	-4,980,000	-2,748,000	-1,791,000	-1,943,000	-2,020,000	-2,568,000	-1,326,220	-1,619,780	-946,653	-1,273,046	11,544	-1,029,310	-764,506	-2,009,351	-2,390,028	-4,696,970	-1,443,068	-7,964,922	-3,199,227	-1,769,978	-1,592,612	-3,605,435	-1,565,381	-2,598,174	-2,787,090	-4,302,421	-4,263,565	-3,155,598	-3,208,341	-3,089,771	-4,009,512	-3,964,436
adjustments to reconcile net income to net cash from operating activities:
share-based compensation expense	11,371,000	9,630,000	10,385,000	10,364,000	10,391,000	9,265,000	9,312,000	8,661,000	8,995,000	8,760,000	7,197,000	7,001,000	7,524,000	7,049,000	7,539,000	6,794,000	7,141,000	6,604,000	6,516,000	5,549,000	6,193,000	4,384,000	5,161,000	4,287,000	4,375,000	4,154,000	4,829,000	4,242,000	3,534,000	3,890,000	3,668,000	3,622,000	3,697,000	3,628,000	2,901,000	2,927,000	3,027,000	2,842,000	2,464,000	2,392,000	2,417,000	1,724,000	1,867,000	1,716,000	1,846,000	2,142,000	1,008,000	734,000	820,000	518,000	527,000	1,112,000	1,140,926	688,074	734,650	803,407	627,745	705,125	626,945	812,035	1,147,753	766,830	860,278	1,110,735	889,720	639,160	576,246	565,877	515,408	493,810	241,059	641,940
depreciation	3,060,000	2,974,000	2,941,000	3,042,000	2,642,000	2,589,000	2,481,000	2,412,000	2,362,000	2,205,000	2,180,000	2,016,000	1,966,000	1,895,000	1,862,000	1,857,000	1,931,000	1,884,000	1,929,000	2,012,000	1,970,000	1,955,000	1,894,000	1,907,000	1,878,000	1,744,000	1,739,000	1,786,000	1,862,000	1,857,000	1,930,000	1,925,000	1,944,000	1,962,000	2,030,000	1,947,000	1,878,000	1,800,000	1,671,000	1,217,000	1,079,000	1,008,000	948,000	899,000	776,000	730,000	552,000	505,000	493,000	458,000	375,000	464,000	571,544	475,456	531,524	512,871	570,710	498,392	535,566	560,338	555,698	532,084	533,300	511,218				655,506	582,398	533,521	477,965	436,853	454,613	414,572	392,369	360,824	427,757	385,923
amortization of intangible assets	2,111,000	2,110,000	1,885,000	1,886,000	1,885,000	1,863,000	1,698,000	1,699,000	1,218,000	738,000	739,000	971,000	971,000	972,000	971,000	971,000	727,000	238,000	238,000	467,000	488,000	489,000	489,000	486,000	484,000	484,000	484,000	342,000	342,000	342,000	341,000	342,000	342,000	342,000	411,000	411,000	411,000	411,000	395,000	302,000	303,000	303,000	355,000	355,000	356,000	355,000	3,000	3,000	3,000	3,000	4,000	3,000	2,875	3,125	16,875	16,875	16,875	40,653	70,375	70,375	70,375	70,375	70,375	70,375				70,375		70,166	53,500	53,500	53,500	53,500	53,500	53,500
amortization of deferred financing costs	119,000	120,000	119,000	120,000	63,000	176,000	122,000	121,000	122,000	121,000	124,000	128,000	127,000	128,000	131,000	379,000	125,000	124,000	86,000	141,000	141,000	141,000	142,000	124,000	54,000	55,000	174,000	124,000	124,000	93,000	66,000	66,000	66,000	66,000	66,000	66,000	71,000	15,000	15,000	15,000	15,000	16,000	14,000	19,000	21,000	59,000	46,000	23,000	25,000	21,000	19,000	12,000	16,723	52,277	20,811	26,151	32,417	27,148	26,332	25,168	23,762	21,215	20,535	21,961				12,231				12,232						12,235
amortization of investments			0	0	0	107,000	171,000	167,000	125,000	169,000	206,000	289,000	424,000	559,000		641,000											-241,000	-65,000	-41,000	-15,000
loss on debt extinguishment			0	0	0	1,362,000
acquired in-process research and development expense
other non-cash adjustments	-184,000	495,000	1,450,000	191,000	344,000	190,000	531,000	485,000	327,000	160,000	-685,000	770,000
changes in operating assets and liabilities:
accounts receivable	-2,158,000	-2,686,000	-6,063,000	893,000	-342,000	-2,789,000	-932,000	-3,377,000	-2,663,000	-2,900,000	-4,000	-228,000	-807,000	-7,950,000	496,000	216,000	-4,103,000	-6,696,000	2,412,000	-2,452,000	-748,000	5,875,000	-1,156,000	814,000	-1,312,000	-1,547,000	-2,110,000	1,219,000	-2,729,000	783,000	-434,000	643,000	-1,276,000	-397,000	-205,000	120,000	-1,927,000	30,000	-1,471,000	1,039,000	2,217,000	-2,685,000	-2,383,000	-337,000	-403,000	-1,045,000	-199,000	414,000	-232,000	-1,231,000	-542,000	1,041,000	-738,722	-177,278	-647,276	179,718	-740,673	-920,692	848,362	-1,486,934	-770,187	939,336	261,112	-1,116,247	2,166,695	635,050	-881,296	-1,311,112	198,341	-173,631	-950,346	364,504	-558,009	-506,678	-108,563	-605,449	-1,095,570	1,872,576
inventories	-824,000	750,000	831,000	-2,684,000	-1,742,000	-4,145,000	-5,793,000	-6,660,000	-6,530,000	-2,847,000	-1,595,000	-2,983,000	-793,000	-1,934,000	-465,000	-1,102,000	-1,443,000	-1,264,000	-519,000	-1,344,000	-674,000	-2,728,000	-1,508,000	-1,677,000	-267,000	-1,699,000	-256,000	-593,000	746,000	-43,000	155,000	-2,538,000	-949,000	-1,145,000	1,155,000	361,000	-363,000	-1,232,000	-489,000	-484,000	-873,000	-1,104,000	212,000	-2,098,000	-1,595,000	-862,000	-975,000	-993,000	-319,000	-1,000	1,184,000	-358,000	488,629	-449,629	23,175	-292,105	935,982	-538,680	-625,372	-622,077	590,535	476,789	-209,165	646,547	-994,683	401,814	450,959	-1,007,321	-1,043,946	249,732	139,516	-726,258
other current assets	2,403,000	-3,885,000	-2,056,000	2,176,000	2,389,000	-3,458,000	-2,256,000	868,000	776,000	-2,472,000	-1,214,000	667,000	1,613,000	-1,581,000	-1,136,000	744,000	583,000	-891,000	-958,000	488,000	492,000	-499,000	-265,000	-224,000	313,000	-1,023,000	58,000	452,000	663,000	-1,540,000	352,000	503,000	1,149,000	-1,175,000	-14,000	372,000	203,000	-439,000	-479,000	89,000	241,000	-779,000	-526,000	261,000	260,000	312,000	-1,374,000	357,000	394,000	-634,000	-65,000	298,000	-43,065	-132,935	-176,713	-76,899	-237,950	231,646	625,958	-95,315	346,917	-260,916	178,790	-95,628	-359,537	-76,052	60,717	32,162	-98,375	-361,549	379,709	-123,837	212,550	-961,469	227,330	119,181
accounts payable	677,000	-722,000	-5,770,000	4,249,000	-2,103,000	2,093,000	2,030,000	1,202,000	-121,000	3,066,000	-2,998,000	1,435,000	2,511,000	1,729,000	183,000	956,000	736,000	2,835,000	-1,045,000	1,455,000	-4,492,000	2,522,000	2,088,000	-1,705,000	1,969,000	438,000	-906,000	940,000	-2,024,000	-408,000	1,235,000	-510,000	212,000	353,000	-316,000	-887,000	-903,000	1,034,000	1,832,000	1,053,000	-996,000	2,124,000	-405,000	397,000	-405,000	-531,000	1,018,000	382,000	-233,000	278,000	335,000	-83,000	-319,139	-64,861	727,452	-69,300	-242,706	888,284	-890,974	1,138,677	-256,948	-520,634	1,107,207	-1,879,715	992,756	465,122	-1,417,104	556,687	1,035,700	-859,764	-527,042	1,523,795	257,149	246,764	-113,090	164,129	-947,985	505,390
accrued liabilities	6,729,000	-12,561,000	5,961,000	7,802,000	2,324,000	-14,888,000	7,248,000	5,398,000	3,735,000	-4,819,000	1,640,000	530,000	5,565,000	-10,701,000	4,284,000	-542,000	2,730,000	1,799,000	8,780,000	1,153,000	-296,000	-14,545,000	3,608,000	5,345,000	2,807,000	-8,652,000	4,262,000	4,451,000	2,547,000	-4,244,000	696,000	3,423,000	936,000	-2,827,000	1,557,000	2,201,000	-104,000	-5,569,000	2,513,000	2,753,000	2,735,000	-4,931,000	1,757,000	3,100,000	1,265,000	-7,969,000	1,797,000	1,942,000	565,000	-190,000	-54,000	-335,000	98,776	193,224	145,956	-938,856	197,869	160,972	676,794	-1,272,706	516,235	344,637	-195,342	-524,906	-1,205,267	833,544	-547,240	173,089	-24,210	405,537	314,733	-1,017,531	994,161	135,570	345,912	-414,953	137,007	206,939
other noncurrent assets and liabilities	-497,000	-504,000	-279,000	-182,000	-463,000	-112,000	-793,000	-399,000	-217,000	216,000	-1,340,000	-117,000	-372,000	47,000	-1,101,000	-1,094,000	-213,000	-358,000	-411,000	388,000	627,000	-120,000	-276,000	-346,000	-205,000	-135,000	44,000	18,000	48,000	21,000	-19,000	79,000	-313,000	-155,000	39,000	146,000	-47,000	-291,000	-105,000	275,000	100,000	28,000		113,000	-871,000	-55,000
net cash from operating activities	21,617,000	-11,026,000	5,836,000	20,004,000	7,380,000	-21,016,000	4,030,000	1,522,000	3,011,000	-4,079,000	46,000	-1,784,000	4,229,000	-24,632,000	301,000	-232,000	-4,533,000	-9,316,000	3,954,000	3,812,000	-11,548,000	-16,087,000	-3,529,000	-2,590,000	3,746,000	-13,438,000	985,000	5,213,000	-935,000	-9,434,000	1,528,000	131,000	-1,057,000	-9,546,000	761,000	1,076,000	-6,025,000	-10,931,000	-4,080,000	2,632,000	2,576,000	-8,970,000	-2,013,000	-1,214,000	-3,975,000	-14,398,000	-3,064,000	674,000	-258,000	-2,574,000	-191,000	-463,000	-198,389	-1,083,611	367,673	-871,574	1,533,663	317,073	1,092,358	-2,976,528	89,955	1,531,295	1,241,238	-2,442,540	-824,400	1,624,585	-2,681,643	-3,828,482	-326,322	-2,166,574	-2,664,162	-2,958,570	-2,516,952	-3,733,169	-2,450,163	-3,765,446	-4,003,654	-893,249
capex	-2,923,000	-1,025,000	-3,543,000	-3,269,000	-2,399,000	-1,914,000	-2,073,000	-3,962,000	-2,821,000	-1,715,000	-5,816,000	-5,790,000	-3,180,000	-1,823,000	-1,764,000	-1,427,000	-3,923,000	-1,087,000	-842,000	-1,700,000	-1,490,000	-929,000	-4,357,000	-3,369,000	-2,519,000	-1,060,000	-1,070,000	-1,686,000	-1,199,000	-1,908,000	-862,000	-2,087,000	-1,616,000	-1,169,000	-1,493,000	-1,824,000	-1,474,000	-2,561,000	-6,323,000	-3,420,000	-1,742,000	-683,000	-6,843,000	521,000	-1,442,000	-896,000	98,000	-618,000	-745,000	-383,000	-39,000	-951,000	-765,539	-606,461	-242,589	-363,159	0	-487,436	-667,735	-332,643	0	-252,710	-40,558	-325,792	-191,748	-584,629	-260,392	-723,296	-805,088	-921,825	-947,784	-275,670	-301,979	-793,230	-508,785	-15,993	-464,785	-602,925
free cash flows	18,694,000	-12,051,000	2,293,000	16,735,000	4,981,000	-22,930,000	1,957,000	-2,440,000	190,000	-5,794,000	-5,770,000	-7,574,000	1,049,000	-26,455,000	-1,463,000	-1,659,000	-8,456,000	-10,403,000	3,112,000	2,112,000	-13,038,000	-17,016,000	-7,886,000	-5,959,000	1,227,000	-14,498,000	-85,000	3,527,000	-2,134,000	-11,342,000	666,000	-1,956,000	-2,673,000	-10,715,000	-732,000	-748,000	-7,499,000	-13,492,000	-10,403,000	-788,000	834,000	-9,653,000	-8,856,000	-693,000	-5,417,000	-15,294,000	-2,966,000	56,000	-1,003,000	-2,957,000	-230,000	-1,414,000	-963,928	-1,690,072	125,084	-1,234,733	1,533,663	-170,363	424,623	-3,309,171	89,955	1,278,585	1,200,680	-2,768,332	-1,016,148	1,039,956	-2,942,035	-4,551,778	-1,131,410	-3,088,399	-3,611,946	-3,234,240	-2,818,931	-4,526,399	-2,958,948	-3,781,439	-4,468,439	-1,496,174
cash flows from investing activities:
sales and maturities of available-for-sale securities			0	8,000,000	33,250,000	12,418,000	0	15,500,000	17,000,000	31,315,000	11,173,000	22,602,000	28,646,000	23,103,000	16,315,000	42,163,000	82,971,000	64,913,000	25,322,000	16,252,000	14,569,000	19,163,000	7,500,000	46,823,000	30,497,000	15,665,000	6,850,000	7,539,000	4,800,000	8,200,000					9,600,000	2,198,000	2,604,000	9,800,000	11,428,000	8,714,000	8,561,000	11,899,000
purchases of property and equipment	-2,662,000	-2,181,000	-2,693,000	-3,608,000	-2,384,000	-2,774,000	-2,786,000	-3,630,000	-3,080,000	-2,502,000	-4,171,000	-5,145,000	-4,184,000	-3,381,000	-2,710,000	-1,504,000	-4,213,000	-1,326,000	-1,052,000	-1,263,000	-1,112,000	-1,832,000	-4,357,000	-3,369,000	-2,747,000	-1,709,000	-1,083,000	-1,655,000	-1,387,000	-2,086,000	-1,249,000	-1,647,000	-1,760,000	-1,728,000	-1,590,000	-1,761,000	-1,537,000	-2,804,000	-5,158,000	-4,210,000	-2,643,000	-1,434,000	-4,818,000	-1,914,000	-1,455,000	-1,020,000		-739,000	-736,000	-455,000		-977,000	-733,046	-661,954	-249,386	-388,734		-497,679	-639,932	-397,076		-248,205
proceeds from sale of property and equipment			0	0																			11,000	20,000	0	8,000	0	0							0
acquisitions, including in-process research and development
proceeds from capital grant	0	500,000																	0	0
net cash from investing activities	-7,662,000	-1,681,000	-14,693,000	4,392,000	30,891,000	9,644,000	-2,786,000	11,870,000	-16,080,000	28,813,000	7,002,000	-3,239,000	20,521,000	19,722,000	1,077,000	-25,101,000	-16,059,000	63,587,000	-1,980,000	-58,737,000	-112,812,000	17,331,000	-2,601,000	-9,633,000	-930,000	11,017,000	-70,826,000	-601,000	-9,732,000	-4,245,000	1,065,000	-2,599,000	-431,000	5,726,000	6,813,000	-5,015,000	-20,873,000	6,996,000	-2,735,000	-9,041,000	-1,282,000	2,557,000	-9,436,000	-5,139,000	-23,462,000	7,414,000	-7,937,000	-5,379,000	614,000	-1,449,000	-11,000	477,000	-2,565,834	-697,166	-4,584,373	69,402	-685,526	-3,302,118	2,423,768	-1,771,059	-1,341,624	-4,063,599	-2,394,154	5,626,929	-163,311	-4,593,968	-680,123	4,266,434	-3,801,524	-7,151,545	891,338	1,275,168	1,591,067	-218,289	-710,817	-547,318	-6,833,193	-6,523,606
cash flows from financing activities:
proceeds from revolving credit facility, net of financing costs			0	0	0	61,210,000
payments on debt and leases	-292,000	-287,000	-281,000	-269,000	-264,000	-62,065,000										-1,870,000	-201,000	-198,000		-188,000	-186,000	-94,000			-153,000	-150,000
payment of financing costs and bank fees			0	-67,000	-142,000	-860,000
proceeds from stock option exercises and employee stock purchase plan								815,000				383,000				1,010,000	4,422,000	4,588,000		523,000	2,853,000	4,036,000		259,000
shares repurchased for payment of taxes on stock awards	-406,000	-10,172,000	-192,000	-63,000	-159,000	-6,537,000	-84,000	-435,000	-299,000	-5,739,000	-65,000	-563,000	-938,000	-10,635,000	-111,000	-1,400,000	-1,403,000	-15,097,000	-100,000	-606,000	-547,000	-11,776,000	-57,000	-281,000	-94,000	-8,601,000	-35,000	-698,000	-59,000	-3,665,000	-22,000	-90,000	-166,000	-1,735,000	-623,000	-45,000	-34,000	-999,000	-132,000	-78,000	-69,000	-503,000	-133,000	-45,000	-65,000	-88,000	-119,000	-10,000	-24,000	-245,000	-29,000	-144,000	-29,927	-198,073	-54,083	-468,445
net cash from financing activities	3,419,000	-10,325,000	1,738,000	-333,000	2,854,000	-7,862,000	2,359,000	132,000	2,994,000	-5,517,000	1,982,000	-405,000	1,861,000	-10,497,000	2,507,000	-2,260,000	2,818,000	-10,707,000	6,453,000	-301,000	191,074,000	-7,834,000	1,354,000	20,293,000	1,696,000	-8,970,000	84,129,000	-430,000	3,414,000	13,063,000	-209,000	882,000	3,311,000	-1,224,000	654,000	124,000	26,127,000	790,000	1,914,000	5,140,000	5,086,000	1,821,000	4,417,000	-47,000	765,000	60,736,000	278,000	-507,000	-80,000	27,137,000	-254,000	-523,000	1,289	3,437,711	677,684	4,331,905	-117,462	-406,875	-379,461	-539,376	-408,947	-624,440	6,178,682	-6,059,304	24,507	5,303,174	364,347	-411,364	-165,875	-1,265,461	16,428,239	31,305	-85,740	-46,891	-82,825	-61,909	-66,131
effect of exchange rate changes on cash and cash equivalents	537,000	196,000	-495,000	237,000	-57,000	-109,000	109,000	-166,000	-26,000	25,000	246,000	-305,000	-196,000	-106,000	-117,000	-140,000	13,000	-128,000			42,000	-127,000	77,000	-135,000	15,000	-120,000	-56,000	-49,000	-110,000	36,000	-19,000	17,000	36,000	-10,000	-127,000	5,000	-80,000	149,000	-49,000	-4,000	48,000	-233,000		-52,000	11,000	-5,000		-11,000	-16,000	-83,000		52,000	4,477	2,523	-34,809	-74,696		63,905	61,936	37,043		2,291	94,105	34,640
net increase in cash and cash equivalents			-7,614,000	24,300,000	41,068,000	-19,343,000	3,712,000	13,358,000	-10,101,000	19,242,000	9,276,000	-5,733,000	26,415,000	-15,513,000	3,768,000	-27,733,000	-17,761,000	43,436,000	8,563,000	-55,141,000			-4,699,000												8,101,000	-3,810,000			-4,950,000	-1,273,000	6,428,000	-4,825,000	-7,142,000	-6,452,000	-26,661,000	53,747,000	-10,929,000	-5,223,000	260,000	23,031,000				1,659,457		3,455,037							5,119,871	-2,840,275		2,256,802	-2,991,137	13,927	-4,229,587	-10,506,010			-925,738				-10,902,978
cash and cash equivalents—beginning of period	0	122,721,000	0	0	0	84,310,000	0	0	0	58,099,000	0	0	0	43,654,000	0	0	0	41,944,000	0	0	0	28,483,000	0	0	0	32,231,000	0	0	0	21,809,000	0	0	0	24,208,000	0	0	0	23,764,000	0	0	0	28,384,000	0	0	0	14,892,000	0	0	0	7,753,000	0	0	97	9,758,903	0	4,230,709	0	0	0	8,905,425	0	0	0	11,448,451	0	0	0	13,000,652
cash and cash equivalents—end of period	17,911,000	99,885,000	-7,614,000	24,300,000	41,068,000	64,967,000	3,712,000	13,358,000	-10,101,000	77,341,000	9,276,000	-5,733,000	26,415,000	28,141,000	3,768,000	-27,733,000	-17,761,000	85,380,000	8,563,000	-55,141,000	66,756,000	21,766,000	-4,699,000	7,935,000	4,527,000	20,720,000	14,232,000	4,133,000	-7,363,000	21,229,000	2,365,000	-1,569,000	1,859,000	19,154,000	8,101,000	-3,810,000	-851,000	20,768,000	-4,950,000	-1,273,000	6,428,000	23,559,000	-7,142,000	-6,452,000	-26,661,000	68,639,000	-10,929,000	-5,223,000	260,000	30,784,000	-450,000	-457,000	-2,758,360	11,418,360	-3,573,825	7,685,746	704,618	-3,328,015	3,198,601	3,655,505	-1,668,169	-3,154,453	5,119,871	8,608,176	-831,793	2,256,802	-2,991,137	13,014,579
supplemental cash flow information:
cash paid for interest	1,328,000	1,246,000	2,350,000	1,426,000	1,449,000	726,000	1,660,000	1,638,000	1,591,000	1,487,000	1,344,000	1,129,000	931,000	866,000	998,000	1,078,000	1,081,000	1,066,000	1,080,000	1,091,000	1,094,000	1,101,000			832,000	914,000	1,127,000	1,533,000	794,000	416,000	505,000	512,000	497,000	488,000	463,000	466,000	333,000	244,000	228,000	1,000	1,000	2,000	2,000	4,000	7,000	102,000	92,000	102,000	139,000	140,000	150,000	160,000	168,815	128,185	109,869	57,175	83,221	97,356	112,119	124,820	145,927	153,263	116,346	45,391	68,381	34,837	9,520	14,918	15,194	17,400	5,152	35,205	37,089	25,787	54,060	42,690	20,102
cash paid for taxes, net of refunds	766,000	116,000
non-cash investing and financing activities:
accrued purchases of property and equipment	-261,000	1,156,000	-850,000	339,000	-15,000	860,000	713,000	-332,000	259,000	787,000	-1,645,000	-645,000	1,004,000	1,558,000	946,000	77,000	290,000	239,000	210,000	-437,000	-378,000	903,000			228,000	649,000	13,000	-31,000	188,000	178,000	387,000	-440,000	144,000	559,000	97,000	-63,000	63,000	243,000	-1,165,000	790,000	901,000	751,000	-2,025,000	2,435,000	13,000	124,000	98,000	121,000	-9,000	72,000	-39,000	26,000	-32,493	55,493
proceeds from stock option exercises		134,000			3,419,000	390,000				522,000				355,000												80,000				1,787,000	232,000	1,096,000	2,443,000	631,000	742,000	294,000	405,000	1,896,000	282,000	567,000	1,338,000	516,000	259,000	20,000	242,000	1,395,000	441,000	37,000	238,000	1,002,000	97,000	128,000	221,233	212,767	818,876	221,382	149,002	169,600	12,398	22,356	23,750				808	64,943	62,423	111,699		18,528	25,104	126,241
net decrease in cash and cash equivalents		-22,836,000																				-6,717,000			4,527,000	-11,511,000		4,133,000	-7,363,000	-580,000		-1,569,000	1,859,000	-5,054,000				-2,996,000														-457,000					704,618			-5,249,920	-1,668,169											-1,704,242			-3,243,805	-4,374,673
purchases of available-for-sale securities											0	-20,696,000			-12,528,000	-65,760,000			-26,250,000	-73,726,000			-6,523,000	-35,099,000	-28,680,000	-2,947,000	-76,593,000	-6,485,000	-13,151,000	-10,359,000	-3,686,000	-5,202,000	-4,471,000	-3,096,000	-1,197,000	-5,455,000			0	-9,223,000	-4,216,000	-6,086,000	-9,695,000	-4,090,000			-12,057,000	-6,642,000	5,000	-2,549,000	-698,000	-1,846,000	-5,195,383	-1,496,617	-6,734,987	-3,281,340	-3,861,639	-3,654,439	-235,393	-3,373,381	-2,191,205	-3,815,394			0	3,218	-1,902,439	-1,535	-4,221,221			-6,761	-806,954	-3,234	-5,125,720	-353,929
proceeds from issuance of common stock under employee stock purchase plan																															905,000	0			631,000	0			633,000	0			612,000	0			464,000	0			255,000	0					273,436	0			160,625	0
cash paid for income taxes, net of refunds											57,000	3,000	82,000	50,000	37,000	25,000	81,000	47,000
acquisition of intellectual property							0	0
net cash paid for income taxes				67,000				69,000
net cash paid (received) for income taxes						17,000
change in fair value of contingent consideration															0																												0	-5,370,000
intangible asset impairment															0
proceeds from debt borrowings																							0				0	0	0	17,381,000					0	0																0	0	10,000,000
payments on debt and finance leases																							-170,000
payment of debt fees							0	0	0	-60,000																	0	0	-22,000	-1,114,000	0	0				0												-1,000	-73,000	-25,000		-2,000	-51,000	-25,000	-50,000	-25,719		-19,462	-60,248	-5,349				-51,037
payments on leases								-248,000	-243,000	-240,000			-220,000	-217,000
net cash (received) paid for income taxes										-12,000
proceeds from sale of stock, net of offering costs of 218
assets obtained in exchange for finance lease obligations
loss on disposal of property and equipment												9,000	7,000	18,000		16,000	35,000	17,000		-4,000	65,000	32,000						9,000				7,000	26,000	62,000			-24,000	141,000		20,000	6,000	57,000
other non-cash adjustments to income														320,000		424,000	218,000	254,000	199,000	215,000	296,000	360,000
amortization (accretion) of investments																		555,000	608,000	501,000
other adjustments to income
changes in operating assets and liabilities, net of amounts acquired:
cash paid for sentreheart business combination
proceeds from economic incentive loan																							0
contingent consideration in business combinations
stock issuance in business combinations
proceeds from sale of stock, net of offering costs of 0 and 218
payments of debt fees																				-30,000				-29,000	-1,000	-299,000
change in value of contingent consideration																	2,600,000	2,500,000		192,000	-7,504,000	2,458,000		-3,062,000	-2,205,000	-1,667,000		-780,000
loss on disposal of property and equipment and impairment of assets																							171,000
payment of contingent consideration in excess of purchase accounting amount																											0
proceeds from sale of stock, net of offering costs of 218, 0, 229
payment of contingent consideration liability previously established in purchase accounting
cash paid for income taxes																					95,000	187,000			49,000	136,000	20,000	0			0																										8,000	0															0	0	33,034	18,500
share-settled portion of contingent consideration																											0
finance lease early termination
stock issuance in business combination
contingent consideration in business combination
working capital adjustment receivable from business combination
proceeds from sale of stock, net of offering costs of 218 and 0, respectively
accretion of investments																						-3,000		-147,000	-344,000	-391,000
non-cash lease expense																							285,000	232,000	131,000	103,000
realized gain from foreign exchange on intercompany transactions																											71,000					-153,000	-31,000	21,000
benefit from doubtful accounts																							2,000
cash paid for business combination
proceeds from sale of stock, net of offering costs of 229
realized income from foreign exchange on intercompany transactions																								125,000															101,000	31,000	51,000	251,000
payment of ncontact contingent consideration in excess of purchase accounting amount
payments of ncontact contingent consideration amounts established in purchase accounting
change in allowance for doubtful accounts																												361,000	7,000	51,000	-23,000	-15,000	2,000	-136,000	7,000	191,000			89,000	-62,000	17,000	100,000	-107,000	41,000	49,000	-17,000	0	-16,000	-6,000	8,000	22,000	-40,000	4,552	14,448	11,513	6,063	4,873	-6,131	3,112	-17,490
(gain) loss on disposal of property and equipment																										261,000
realized (gain) income from foreign exchange on intercompany transactions																										72,000			138,000	-82,000						-8,000
payments on debt and capital leases																											-147,000	-139,000	-143,000	-1,326,000									-227,000	-11,000	-11,000	-14,000	-20,000	-10,000	-9,000	-6,343,000	-508,000	-533,000	-507,000	-507,000	-528,000	-505,000	-511,017	-6,551,983	-382,961	-2,895,313	-557,340	-557,013	-556,695	-556,383	-565,225	-550,245	-369,532	-6,008,267	-8,116	-492,662
assets acquired through capital lease																											0	0	-3,000	27,000	0				27,000	82,000			0	14,000	0	36,000	39,000	0			0				60,000				0	26,655									0	0	0	102,197
capital lease asset early termination																																			9,000	19,000											0
proceeds from exercise of stock options and employee stock purchase plan																												1,532,000
payments of contingent consideration amounts established in purchase accounting
amortization/accretion on investments																															-12,000	-17,000	21,000	38,000	30,000	22,000	18,000	56,000	105,000	133,000	155,000	184,000	178,000	159,000	80,000	83,000	53,000	2,000	-3,000	-3,000	-4,000	-3,000	8,342	10,658
increases in property under build-to-suit obligation																																							-1,424,000	-4,322,000	-2,984,000	-1,822,000
cash paid for ncontact business combination
proceeds from build-to-suit obligation
payment of stock issuance fees
maturities of available-for-sale securities																																4,250,000	5,800,000	10,550,000										865,000	2,850,000	2,550,000	1,300,000	2,000,000	1,345,000	1,555,000	1,300,000	3,300,000	3,362,500	1,437,500	2,400,000	3,650,000	3,450,000	850,000	3,299,093	1,999,398					0	1,894,670	1,900,000	5,100,000	1,200,000	1,000,000	1,800,000	1,808,000	2,700,000	500,000
payments on capital leases																																-124,000	-121,000	-120,000		-125,000	-111,000	-107,000
loss on disposal of equipment and impairment of assets
other																																											0	0	0	95,000
proceeds from sale of stock, net of offering costs of 257 in 2014
payment of debt fees and premium on retirement of debt																																							0	0			0	-12,000	-69,000	-100,000																			-71,825
cash paid for taxes																																							0	0				0	0	146,000		0	0	30,000		2,000	500	11,500	2,780	15,000				21,639
net income on disposal of property and equipment
increases in build-to-suit obligation																																								4,322,000	2,984,000	1,822,000
proceeds from tax incentive loan
gain on disposal of property and equipment
cash acquired through estech business combination
proceeds from sale of stock, net of offering costs of 0, 257 and 212, respectively
proceeds from sale of stock, net of offering costs of 0 and 257, respectively
proceeds from sale of stock, net of offering costs of 0 and 215, respectively
income from foreign exchange on intercompany transactions
changes in assets and liabilities:
other non-current assets and non-current liabilities																																															23,000	68,000	12,000	127,000	-24,000	-3,000	-107,665	-63,335	-74,672	14,289	353,442	217,093	-89,229	-132,855	20,268	57,350	-130,590	-32,699	79,909	-230,573
cash acquired through business combination
proceeds from sale of stock, net of offering costs of 257 and 212, respectively																																											0	0
proceeds from construction financing obligation
proceeds from borrowings of debt																																																								7,500,000									0
effect of exchange rate changes on cash																																																																	131,411	-76,989	6,282	-12,661	64,134	77,570	-105,307	-52,145
noncash investing and financing activities:
stock issuance for estech acquisition
contingent consideration for acquisition of estech
loss on disposal of equipment																																												-3,000	0	14,000									1,031	44,450					-10,345	12,779	0	3,083
sales of available-for-sale securities																																												0	2,465,000	5,884,000
net proceeds from the sale of equipment																																																				0	95	23,905	0	89,476
proceeds from sale of stock, net of offering costs of 215 and 172, respectively																																														65,872,000
non-cash investing activities:
write-off of deferred financing costs and discount on long-term debt																																																							0	153,101
amortization of discount on long-term debt																																																							0	21,707	38,576	44,136	48,995	53,607	59,765	64,684
(gain) loss on disposal of equipment																																																			52,000	-3,000	4,055	-13,055			-35,041
gain on sale of intellectual property
purchases of equipment
proceeds from sale of equipment
proceeds from sale of intellectual property
proceeds from sale of stock, net of offering costs of 212																																															0	0
gain on disposal of equipment																																																1,000	14,000	15,000																				0	2,996	3,856		0	0	-20,000
proceeds from sale of stock, net of offering costs of 172																																																		26,912,000
receivable related to sale of property and equipment
goodwill impairment																																																													0	0	0	6,812,389
settlement reserve																																																													188,782
change in restricted cash and cash equivalents																																																													0	0	0	6,000,000	0
warrant issued in conjunction with credit facility																																																													0
purchases of property and equipment in current liabilities																																																							6,797	25,575		10,243	-27,803	64,433		-4,505	-40,558	47,279	-28,437	-92,773
write-off of deferred financing costs																																																													0	0
changes in assets and liabilities, excluding effects of acquired business:
cash paid for acquisition																																																																	0	0
purchases of equipment in current liabilities
proceeds from sale of equipment in accounts receivable																																																																											0	20,000
(benefit from) benefit from losses in accounts receivable
net proceeds from sale of common stock
unsecured note payable in connection with acquisition
change in benefit from losses in accounts receivable																																																														-42,887	40,664	-4,731
changes in assets and liabilities, excluding effects of acquired businesses:
proceeds from borrowings of long-term debt																																																														0
payment of debt origination fees
warrant issued in connection with credit facility
purchases of property & equipment																																																																-373,071	-163,311	-491,856	-260,392	-832,031	-776,057	-826,995	-915,423	-526,071	-301,979	-735,055	-450,097	-193,389	-464,785	-602,925
change in benefit from allowance for doubtful accounts
proceeds from sale of property & equipment																																																																									0
net proceeds from sale of stock
unsecured note payable in connection with the acquisition
depreciation and amortization																																																																		741,753
benefit from losses in accounts receivable																																																																		-15,255
gross proceeds from sale of stock
accrued issuance costs from private placement
benefit from losses accounts receivable																																																																				42,872
other non-current assets and other non-current liabilities																																																																				-13,413	4,020	2,124	11,704	241,421
payments on long-term debt and capital leases																																																																				-523,063	-100,883	-100,994	-96,862	-94,936
purchases of property & equipment in current liabilities																																																																				108,735	-29,031	-94,830	-32,361	250,401
amortization
preferred stock interest																																																																													0	379,669
changes in assets and liabilities
cash paid for acquisition, net of cash acquired
proceeds from long-term debt borrowings																																																																													0
proceeds from stock option exercises and warrants																																																																									8,627			29,150
warrants issued in connection with line of credit																																																																													0	0
preferred stock conversion																																																																													0
amortization of warrants																																																																						12,231				12,231	12,230	12,232
benefit from accounts receivable
net proceeds from private placement of common shares
cash and cash equivalents - beginning of period																																																																						0	0	14,890,383		0	0	27,432,948		0
cash and cash equivalents - end of period																																																																						-10,506,010	14,550,108	13,186,141		-3,998,349	-3,243,805	23,058,275		37,245,246
(benefit from) benefit from losses on accounts receivable
gross proceeds from private placement of common shares
benefit from losses on accounts receivable																																																																								-66,624
proceeds from stock offering, net of related fees
stock compensation																																																																										180,495	271,550	197,377	175,301	153,113
inventory																																																																										-193,885	-347,140	-573,386	289,577	-17,770
other non-current assets and liabilities																																																																										41,329	24,080	30,870
cash flow from financing activities:
payments on long-term debt																																																																										-85,347	-83,662	-82,010	-76,662
payments on capital lease obligations																																																																										-7,789	-7,611	-9,049	-10,677
proceeds from stock offering																																																																													0
purchases of property & equipment in accounts payable																																																																										-55,009	4,663	55,836
purchases of property & equipment in accrued liabilities																																																																										-3,166	-63,351	121,560
advance payments for acquisition of company
changes in assets and liabilities, excluding the effects of acquisition:
prepaid expenses																																																																													282,488	-869,920
other assets																																																																													-2,435	283,897
commissions payable																																																																													414,180	129,413
amortization of intangible asset
proceeds from stock option exercise and warrants
proceeds from stock option exercise

We provide you with 20 years of cash flow statements for AtriCure stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of AtriCure stock. Explore the full financial landscape of AtriCure stock with our expertly curated income statements.

The information provided in this report about AtriCure stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.